Zhang, Wei
Li, Dong
Liu, Shan
Tang, Jiying
Cai, Xiaojun
Zuo, Zhigang
Li, Chaofu
Liu, Yuhan
Zeng, Langhong
Zhao, Yi
Article History
Received: 18 December 2025
Accepted: 19 May 2026
First Online: 2 June 2026
Declarations
:
: The clinical study was approved by the Ethics Committee of Shiyan Municipal People’s Hospital (Approval No.SYRMYY-2025-098). Informed consent was obtained from all individual participants included in the study. This study was performed in line with the principles of the Declaration of Helsinki. The animal study was approved by the Ethics Committee of MDKN Biotechnology Co., Ltd. All animal experiments complied with the ARRIVE guidelines. All methods were carried out in accordance with relevant guidelines and regulations.
: The authors declare no competing interests.